Latest Financial Position News

DXN Limited reported a modest 2% revenue increase to $2.5 million in Q3 FY25, launched its Data Centre as a Service division with a $3.6 million initial contract, and progressed a key acquisition valued at $10 million, positioning itself for growth despite some project delays.

LCL Resources has struck a binding agreement to divest its Colombian projects for A$10 million plus royalties, while unveiling a maiden 831,000-ounce gold resource at its Kusi project in Papua New Guinea.

Carnegie Clean Energy has advanced its ACHIEVE Programme with a key contract for CETO deployment at the Basque Marine Energy Platform, securing milestone payments exceeding €1.5 million and launching a new Investor Hub to enhance shareholder engagement.

QPM Energy reports a substantial 61% upgrade in Moranbah Gas Project reserves to 435PJ, successfully integrates Moranbah Power Station operations, and begins overhaul of Townsville Power Station, navigating weather disruptions and contract renewals.

Linius Technologies embarks on a strategic transformation under CEO Ben Taverner, focusing on operational restructuring, AI-enhanced SaaS products, and market expansion beyond sports to achieve breakeven by June 2026.

HyTerra Ltd has commenced drilling at its flagship Nemaha Project in Kansas and reported promising hydrogen and helium gas compositions from its Geneva Project in Nebraska, underscoring its leadership in natural hydrogen exploration in the US.

ABx Group Limited reports significant progress in rare earths exploration in Tasmania, ALCORE fluorine recycling pilot plant development, and bauxite project advancements, positioning itself amid tightening global supply chains.

Comet Ridge Limited reports significant progress on its Mahalo Gas Hub project, with upstream and pipeline FEED studies advancing, robust pilot production at Mahalo East, and active negotiations on gas sales and funding arrangements.

Legacy Minerals has significantly upgraded its Drake Project resource to 0.8 million ounces gold-equivalent and reported a robust Stage 1 Scoping Study, setting the stage for potential production growth. Exploration momentum continues across its NSW portfolio with ongoing drilling and geophysical surveys.

Little Green Pharma reported a robust 40% revenue increase for FY25, driven by strong European sales and the strategic acquisition of Health House. The company also advanced clinical research and secured new therapy funding, positioning itself for continued growth.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.

Horizon Oil reported steady Q3 FY25 production and cash flow, paid its fifth consecutive interim dividend, and announced a strategic acquisition in Thailand that promises to boost production and diversify its asset base.